Atrovent 500 Mcg Vials

Atrovent 500 Mcg Vials

Description:

Atrovent 500 mcg/2 ml unit dose vials is a prescription bronchodilator medicine containing ipratropium bromide, an anticholinergic (muscarinic antagonist) used for inhalation via nebulizer. It is indicated for the management of chronic obstructive pulmonary disease (copd), chronic bronchitis, emphysema, and acute bronchospasm, helping to open the airways and improve breathing. Atrovent works locally in the bronchial smooth muscle to reduce cholinergic constrictor tone without affecting the volume or consistency of respiratory secretions or impairing mucociliary clearance. Each sterile unit dose vial is designed for single use in nebulized form under medical supervision.

Indications:

• Maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (copd), including chronic bronchitis and emphysema.
• Relief and prevention of bronchospasm in patients with reversible airway obstruction when an anticholinergic bronchodilator is indicated.
• Adjunctive therapy in acute bronchospasm (e.g., asthma exacerbations) as directed by a physician, often in combination with beta2-agonists.
• Management of chronic bronchitis with associated wheezing, shortness of breath, and chest tightness.
• Supportive treatment to improve airflow and reduce airway resistance in obstructive airway diseases.

Active Ingredients / Key Components:

• Ipratropium bromide – 500 mcg per 2 ml unit dose vial (0.5 mg/2 ml) for inhalation via nebulizer.
• Excipients: The full list of inactive ingredients (e.g., sodium chloride, purified water, stabilizers or preservatives) is not available in the provided information. Please refer to the official package leaflet for complete excipient details.

Dosage & Administration / How to Use:

• Atrovent 500 mcg/2 ml is for inhalation use only via a suitable nebulizer device; do not inject or swallow.
• Adults (including elderly): Typical dose is 500 mcg (1 unit dose vial of 2 ml) administered via nebulizer, usually 3–4 times daily, or as directed by the treating physician. Do not exceed the prescribed frequency.
• Pediatric use: Dosing in children must be determined strictly by a pediatrician or pulmonologist. Do not use in children without medical advice.
• Administration: Empty the contents of one unit dose vial into the nebulizer chamber. If instructed by your doctor, it may be diluted with sterile normal saline to the required volume. Connect the nebulizer to the compressor and inhale the mist calmly and deeply through the mouthpiece or face mask until the solution is fully nebulized (usually 5–15 minutes).
• Use the solution immediately after opening the unit dose vial. Discard any unused solution; do not store opened vials.
• Can be used with or without food, as the medicine acts locally in the lungs.
• Do not mix Atrovent with other inhalation solutions in the nebulizer unless specifically advised by your doctor or pharmacist.
• If a dose is missed, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed one.

Clinical Benefits:

• Provides effective bronchodilation by relaxing bronchial smooth muscle and reducing airway constriction in copd and chronic bronchitis.
• Improves airflow and lung function, helping to relieve symptoms such as wheezing, shortness of breath, and chest tightness.
• Acts locally in the airways with minimal systemic absorption compared to some other bronchodilators, which may reduce systemic side effects.
• Does not significantly alter the volume or consistency of respiratory secretions and does not depress mucociliary clearance, helping to maintain normal airway defense mechanisms.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to ipratropium bromide, atropine or its derivatives, or any of the excipients.
• Use with caution in patients with narrow-angle glaucoma, prostatic hyperplasia, or bladder neck obstruction, as anticholinergic effects may worsen these conditions.
• Avoid contact of the nebulized mist with the eyes, especially in patients with glaucoma; this may cause eye pain, blurred vision, or increased intraocular pressure.
• If paradoxical bronchospasm (sudden worsening of breathing or wheezing) occurs after inhalation, discontinue Atrovent immediately and seek urgent medical attention.
• Consult your doctor before use if pregnant or planning pregnancy. Use during pregnancy only if clearly needed and prescribed.
• Consult your doctor before use if breastfeeding; it is not known to what extent ipratropium bromide passes into breast milk.
• Use with caution and under medical supervision in patients with cardiovascular disease, arrhythmias, or hyperthyroidism when used in combination with other bronchodilators.
• Consult your doctor before use if you are taking other medications, especially other anticholinergics or inhaled bronchodilators, to avoid additive effects.
• Keep out of reach of children.
• This product is a prescription medicine and should be used only under the supervision of a qualified healthcare professional.

Side Effects:

• Common side effects may include dry mouth, throat irritation, cough, hoarseness, nausea, or mild headache.
• Less common side effects can include dizziness, gastrointestinal discomfort, constipation, or skin rash.
• Eye-related effects (if mist contacts the eyes) may include blurred vision, eye pain, redness, or halos around lights, particularly in patients with narrow-angle glaucoma.
• Allergic reactions such as rash, itching, swelling of the face, lips, tongue, or throat, and difficulty breathing are rare but serious. Discontinue use and seek immediate medical attention if these occur.
• If you experience worsening shortness of breath, chest pain, severe dizziness, or any unusual or persistent symptoms, contact your doctor promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight, excessive heat, and moisture. Do not freeze. Keep the unit dose vials in the original foil pouch or packaging until use to protect from light. Do not use after the expiry date printed on the pack. Keep container tightly closed where applicable. Keep out of reach of children.

Specifications:

• Form: Inhalation solution in unit dose vials for nebulization.
• Strength: 500 mcg ipratropium bromide per 2 ml unit dose vial (0.5 mg/2 ml).
• Pack size: 20 unit dose vials per pack (20 x 2 ml).
• Route of administration: Inhalation via nebulizer only.
• Intended users: Adults and children as prescribed by a healthcare professional for obstructive airway diseases.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.